Eagle Pharmaceuticals Inc. (EGRX): Douglas Braunstein of Hudson Executive Capital Appointed Chairman

Page 6 of 7 – SEC Filing
CUSIP No.  269796108
SCHEDULE 13D
Page 6 of 6 Pages

ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Exhibit 1
Company Press Release Announcing the Appointment of Directors (incorporated by reference to Item 5.02 to the Current Report on Form 8-K of Eagle Pharmaceuticals, Inc., filed July 5, 2016).
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date:  July 5, 2016
HUDSON EXECUTIVE CAPITAL LP
By: HEC Management GP, LLC, its general partner
By:
/s/ Douglas L. Braunstein*
Name:       Douglas L. Braunstein
Title:         Managing Member
DOUGLAS L. BRAUNSTEIN
By:
/s/ Douglas L. Braunstein*
Douglas L. Braunstein
JAMES C. WOOLERY
By:
/s/ James C. Woolery*
James C. Woolery
* by John F. Brown, attorney-in-fact

Follow Eagle Pharmaceuticals Inc. (NASDAQ:EGRX)